Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vyvanse vs Concerta in adolescents with ADHD
NCT01552902Phase 4Completed
- Sponsor
- Takeda
- Start
- Apr 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of lisdexamfetamine in attention deficit hyperactivity disorder (ADHD), sponsored by Takeda. Started Apr 2012; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01552902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01552902.